Skip to main content
Duality Biotherapeutics, Inc. logo

Duality Biotherapeutics, Inc. — Investor Relations & Filings

Ticker · 9606 LEI · 254900HZFACBOBP9HN21 HKEX Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2026-04-29 Declaration of Voting R…
Country KY Cayman Islands
Listing HKEX 9606

About Duality Biotherapeutics, Inc.

https://www.dualitybiologics.com/

Duality Biotherapeutics, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of next-generation Antibody-Drug Conjugates (ADCs). The company focuses on creating innovative therapeutics for oncology and autoimmune diseases. Duality operates four proprietary ADC technology platforms—DITAC, DIBAC, DIMAC, and DUPAC—which form the foundation of its robust pipeline. This pipeline currently comprises 12 self-developed ADC candidates, including 7 clinical-stage assets, next-generation bispecific ADCs, and candidates specifically designed for autoimmune conditions. Duality aims to expand the therapeutic boundaries of ADCs through its advanced design insights and execution capabilities.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON APRIL 29, 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an announcement of the poll results from an Extraordinary General Meeting, detailing how each resolution was voted on by shareholders at the meeting. This matches the definition of a declaration of voting results and voting rights announcement (Code: DVA).
2026-04-29 English
2025 Environmental, Social and Governance Report
Environmental & Social Information Classification · 1% confidence The document is titled "Environmental, Social and Governance Report 2025" and contains detailed sections on governance, products, environment, employees, society, key performance tables, and ESG reporting indices. It is a full ESG report rather than a brief announcement or presentation. This matches the definition for Environmental & Social Information (ESG Report) category.
2026-04-26 English
2025 Annual Report
Annual Report Classification · 1% confidence The document is explicitly titled '2025 ANNUAL REPORT' for Duality Biotherapeutics, Inc. It contains a comprehensive table of contents including financial highlights, management discussion and analysis, directors' report, corporate governance report, and full consolidated financial statements (balance sheet, cash flows, etc.). It meets the criteria for a full annual report as it covers the entire fiscal year 2025 and provides substantive financial data. FY 2025
2026-04-26 English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON APRIL 29, 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a form of proxy for an extraordinary general meeting, providing voting instructions and proxy appointment details, clearly aimed at soliciting shareholder votes. This fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-14 English
NOTICE OF THE EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of an extraordinary general meeting, outlining resolutions to be voted on, proxy appointment details, record dates, and procedural instructions for shareholders. This matches the definition of “Proxy Solicitation & Information Statement” (materials sent to shareholders to provide information and request votes for meetings, including EGM notices).
2026-04-14 English
(1) PROPOSED ISSUE OF RMB SHARES UNDER SPECIFIC MANDATE AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTION; (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED ISSUE; AND (
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a comprehensive shareholder circular (“THIS CIRCULAR IS IMPORTANT…”) convening an Extraordinary General Meeting (EGM), including a Notice of EGM, a form of proxy, a Letter from the Board, detailed resolutions (proposed RMB Share Issue, amendments to Articles), definitions, and multiple appendices. It is clearly proxy solicitation material rather than an announcement of results or a financial report. Under the filing definitions, this corresponds exactly to a Proxy Solicitation & Information Statement (PSI).
2026-04-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.